Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 44,871 | 41,256 | -13,579 | -56,418 | -40,891 |
| Depreciation Amortization | -293 | 73 | 86 | -799 | -441 |
| Income taxes - deferred | -11,549 | -12,543 | -1,852 | -7,573 | -984 |
| Accounts payable and accrued liabilities | -29 | -567 | 166 | 750 | -38 |
| Other Working Capital | 192,853 | 209,733 | 51,979 | 20,355 | 6,468 |
| Other Operating Activity | 18,752 | 13,161 | 6,239 | 32,150 | 25,253 |
| Operating Cash Flow | $244,605 | $251,113 | $43,039 | $-11,535 | $-10,633 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 15,838 | N/A |
| PPE Investments | -34 | -34 | N/A | -332 | -142 |
| Purchase Of Investment | -183,288 | -58,542 | -1,968 | -140,743 | -103,022 |
| Sale Of Investment | 77,450 | 52,950 | 32,600 | 139,813 | 99,762 |
| Other Investing Activity | 0 | 0 | 0 | -2,292 | 0 |
| Investing Cash Flow | $-105,872 | $-5,626 | $30,632 | $12,284 | $-3,402 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 298 | 20 | 20 | 607 | 444 |
| Common Stock Repurchased | -2,055 | -1,377 | -874 | -3,104 | -2,576 |
| Financing Cash Flow | $-1,757 | $-1,357 | $-854 | $-2,497 | $-2,132 |
| Beginning Cash Position | 38,633 | 38,633 | 38,633 | 40,381 | 40,381 |
| End Cash Position | 175,609 | 282,763 | 111,450 | 38,633 | 24,214 |
| Net Cash Flow | $136,976 | $244,130 | $72,817 | $-1,748 | $-16,167 |
| Free Cash Flow | |||||
| Operating Cash Flow | 244,605 | 251,113 | 43,039 | -11,535 | -10,633 |
| Capital Expenditure | -34 | -34 | 0 | -332 | -142 |
| Free Cash Flow | 244,571 | 251,079 | 43,039 | -11,867 | -10,775 |